Abstract
Breast Milk (BM) is the best source of nutrition for newborns, especially if premature. In fact, its beneficial impact on short- and the long-term neonatal outcome has was deeply described.
Unfortunately, BM could not be always so safe, especially due to the possible presence of maternal viruses that can be shed and transferred to the breastfed neonate. Among these, Cytomegalovirus (CMV) can potentially lead to a serious and acute illness, mostly in case of low gestational age.
Some studies also report the association of CMV-acquired infection to an increased risk of structural and functional brain modifications and neurological impairment.
Due to these reasons, a strategy to remove CMV from BM with a minimal or absent impact on its beneficial components would be desirable.
Up to now, pasteurization, freezing, ultraviolet- C or microwave irradiation are the available techniques; they show different levels of efficacy and variable effects on BM composition, even if many studies are still needed to fully clarify these implications.
In this review, we provide an update of the current evidence about these topics. We focus on the factors promoting CMV shedding through BM; moreover, the possible occurrence of a severe disease in preterm neonates is also described. Finally, we investigate the potential effects showed on BM properties by the strategies that prevent or reduce viral transmission, therefore influencing newborns’ health, and the new techniques which could show a relevant role in the next future, such as metabolomics.
Keywords: Breast milk, cytomegalovirus, preterm newborns, pasteurization, freezing, irradiation.
Graphical Abstract
[1]
Yoo HS, Sung SI, Jung YJ, et al. Prevention of cytomegalovirus transmission via breast milk in extremely low birth weight infants. Yonsei Med J 2005; 56: 998-1006.
[2]
Lawrence RA. The evidence for growth standards and iron in moderation and exclusive breastfeeding. Breastfeed Med 2006; 1: 205-6.
[3]
Hamprecht K, Maschmann J, Jahn G, Poets CF, Goelz R. Cytomegalovirus transmission to preterm infants during lactation. J Clin Virol 2008; 41: 198-205.
[4]
Vohr BR, Poindexter BB, Dusick AM, et al. Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age. Pediatrics 2007; 120: 953-9.
[5]
American Academy of Pediatrics. Breastfeeding and the use of human milk. Pediatrics 2012; 129: 827-41.
[6]
Romero-Gomez MP, Cabrera M, Montes-Bueno MT, et al. Evaluation of cytomegalovirus infection in low-birth weight children by breast milk using a real-time polymerase chain reaction assay. J Med Virol 2015; 87: 845-50.
[7]
Bardanzellu F, Fanos V, Reali A. “Omics” in human colostrum and mature milk: Looking to old data with new eyes. Nutrients 2017; 9: 83.
[8]
Jim WT, Chiu NC, Ho CS, et al. Outcome of preterm infants with postnatal Cytomegalovirus infection via breast milk. Medicine 2015; 94: e1835.
[9]
Victora CG, Horta BL, Loret de Mola C, et al. Association between breastfeeding and intelligence, educational attainment, and income at 30 years of age: A prospective birth cohort study from Brazil. Lancet Glob Health 2015; 3: e199-205.
[10]
Bryant P, Morley C, Garland S, Curtis N. Cytomegalovirus transmission from breast milk in premature babies: Does it matter? Arch Dis Child Fetal Neonatal Ed 2002; 87: F75-7.
[12]
Dougherty D, Luther M. Birth to breast-a feeding care map for the NICU: helping the extremely low birth weight infant navigate the course. Neonatal Netw 2008; 27: 371-7.
[13]
Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 2001; 357: 513-8.
[14]
Omarsdottir S, Casper C, Zweygberg Wirgart B, Grillner L, Vanpee M. Transmission of cytomegalovirus to extremely preterm infants through breast milk. Acta Paediatr 2007; 96: 492-4.
[15]
Pass RF, Anderson B. Mother-to-child transmission of cytomegalovirus and prevention of congenital infection. J Ped Infect Dis Soc 2014; 3: 2-6.
[16]
Hamprecht K, Goelz R. Postnatal cytomegalovirus infection through human milk in preterm infants transmission, clinical presentation, and prevention. Clin Perinatol 2017; 44: 121-30.
[17]
Schleiss MR. Congenital cytomegalovirus infection: Molecular mechanisms mediating viral pathogenesis. Infect Disord Drug Targets 2011; 11: 449-65.
[18]
Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The ‘Silent’ Global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013; 26: 86.
[19]
Lee HC, Enright A, Benitz WE, Madan A. Postnatal cytomegalovirus infection from frozen breast milk in preterm, low birth weight infants. Pediatr Infect Dis J 2007; 26: 276.
[20]
Chiavarini M, Bragetti P, Sensini A, et al. Breastfeeding and transmission of cytomegalovirus to preterm infants. Case report and kinetic of CMV-DNA in breast milk. Ital J Pediatr 2011; 37: 6.
[21]
Kurath S, Halwachs-Baumann G, Müller W, Resch B. Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review. Clin Microbiol Infect 2010; 16: 1172-8.
[22]
Dollard S, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007; 17: 355-63.
[23]
Balcells C, Botet F, Gayete S, et al. Vertically transmitted cytomegalovirus infection in newborn preterm infants. J Perinat Med 2016; 44: 485-90.
[24]
Ross SA, Boppana SB. Congenital cytomegalovirus infection: Outcome and diagnosis. Semin Pediatr Infect Dis 2005; 16: 44-9.
[26]
Vochem M, Hamprecht K, Jahn G, Speer CP. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J 1998; 17: 53-8.
[27]
Hamprecht K, Witzel S, Maschmann J, et al. Rapid detection and quantification of cell free cytomegalovirus by a high-speed centrifugation-based microculture assay: Comparison to longitudinally analyzed viral DNA load and pp67 late transcript during lactation. J Clin Virol 2003; 28: 303-16.
[28]
Hamprecht K, Maschmann J, Muller D, et al. Cytomegalovirus (CMV) inactivation in breast milk: Reassessment of pasteurization and freeze-thawing. Pediatr Res 2004; 56: 529-35.
[29]
Hayes K, Danks DM, Gibas H, Jack I. Cytomegalovirus in human milk. N Engl J Med 1972; 287: 177-8.
[30]
Reynolds DW, Stagno S, Hosty TS, Tiller M, Alford CA. Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med 1973; 289: 1-5.
[31]
Hamprecht K, Vochem M, Baumeister A, Boniek M, Speer CP, Jahn G. Detection of cytomegaloviral DNA in human milk cells and cell free milk whey by nested PCR. J Virol Methods 1998; 70: 167-76.
[32]
Stagno S, Reynolds DW, Pass RF, Alford CA. Breast milk and the risk of cytomegalovirus infection. N Engl J Med 1980; 302: 1073-6.
[33]
Dworsky M, Yow M, Stagno S, Pass RF, Alford C. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 1983; 72: 295-9.
[34]
Boeckh M, Boivin G. Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Clin Microbiol Rev 1998; 11: 533-54.
[35]
Ahlfors K, Ivarsson SA. Cytomegalovirus in breast milk of Swedish milk donors. Scand J Infect Dis 1985; 17: 11-3.
[36]
Benson JW, Bodden SJ, Tobin JO. Cytomegalovirus and blood transfusion in neonates. Arch Dis Child 1979; 54: 538-41.
[37]
Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG. Prevention of transfusion acquired cytomegalovirus infections in newborn infants. J Pediatr 1981; 98: 281-7.
[38]
Stagno S, Pass RF, Dworsky ME, Alford CA. Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol 1982; 25: 563-76.
[39]
Griffiths PD, Baboonian C. A prospective study of primary cytomegalovirus infection during pregnancy: Final report. Br J Obstet Gynaecol 1984; 91: 307-15.
[40]
Leurez-Ville M, Sellier Y, Salomon LJ, Stirnemann JJ, Jacquernard F, Wille Y. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: A retrospective cohort. Clin Infect Dis 2013; 56: 1428-35.
[41]
Gindes L, Teperberg-Oikawa M, Pardo J, Rahav G. Congenital cytomegalovirus infection following primary maternal infection in the third trimester. BJOG 2008; 115: 830-5.
[42]
Pass RF, Zhang C, Evans A, et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009; 360: 1191-9.
[43]
Liesnard C, Donner C, Brancart F, Gosselin F, Delforge ML, Rodesch F. Prenatal diagnosis of congenital cytomegalovirus infection: Prospective study of 237 pregnancies at risk. Obstet Gynecol 2000; 95: 881-8.
[44]
Preece PM, Pearl KN, Peckham CS. Congenital cytomegalovirus infection. Arch Dis Child 1984; 59: 1120-6.
[45]
Lanzieri TM, Dollard SC, Josephson CD, Schmid TS, Bialek SR. Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants. Pediatrics 2013; 131: 1937-45.
[46]
Nijman J, de Vries LS, Koopman-Esseboom C, Uiterwaal CS, van Loon AM, Verboon-Maciolek MA. Postnatally acquired cytomegalovirus infection in preterm infants: A prospective study on risk factors and cranial ultrasound findings. Arch Dis Child Fetal Neonatal Ed 2012; 97: F259-63.
[47]
Maschmann J, Hamprecht K, Dietz K, Jahn G, Speer CP. Cytomegalovirus infection of extremely low-birth weight infants via breast milk. Clin Infect Dis 2001; 33: 1998-2003.
[48]
Nijman J, van Loon AM, de Vries LS, et al. Urine viral load and correlation with disease severity in infants with congenital or postnatal cytomegalovirus infection. J Clin Virol 2012; 54: 121-4.
[49]
Hayashi S, Kimura H, Oshiro M, et al. Transmission of cytomegalovirus via breast milk in extremely premature infants. J Perinatol 2011; 31: 440-5.
[50]
Okulu E, Akin IM, Atasay B, Ciftçi E, Arsan S, Türmen T. Severe postnatal cytomegalovirus infection with multisystem involvement in an extremely low birth weight infant. J Perinatol 2012; 32: 72-4.
[51]
Josephson CD, Caliendo AM, Easley KA, et al. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: A prospective cohort study. JAMA Pediatr 2014; 168: 1054-62.
[52]
Jim WT, Shu CH, Chiu NC, et al. Transmission of cytomegalovirus from mothers to preterm infants by breast milk. Pediatr Infect Dis J 2004; 23: 845-51.
[53]
Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 17: 253-76.
[54]
Hotsubo T, Nagata N, Shimada M, Yoshida K, Fujinaga K, Chiba S. Detection of human cytomegalovirus DNA in breast milk by means of polymerase chain reaction. Microbiol Immunol 1994; 38: 809-11.
[55]
Meier J, Lienicke U, Tschirch E, Kruger DH, Wauer RR, Prösch S. Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants. J Clin Microbiol 2005; 43: 1318-24.
[58]
Hamprecht K, Maschmann J, Vochem M, Speer CP, Jahn G. Transmission of cytomegalovirus to preterm infants by breastfeeding. In: Prösch S, Cinatl J, Scholz M, Eds. New aspects of CMV-related immunopathology, 24. Basel, Switzerland: Karger P 2003; pp. 43-52.
[59]
Yasuda A, Kimura H, Hayakawa M, et al. Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants with a real-time polymerase chain reaction assay. Pediatrics 2003; 111: 1333-6.
[60]
Schanler RJ. Suitability of human milk for the low-birth weight infant. Clin Perinatol 1995; 22: 207-22.
[61]
Maschmann J, Hamprecht K, Weissbrich B, Dietz K, Jahn G, Speer CP. Freeze-thawing of breast milk does not prevent cytomegalovirus transmission to a preterm infant. Arch Dis Child Fetal Neonatal Ed 2006; 91: F288-90.
[62]
Clarke NM, May JT. Effect of antimicrobial factors in human milk on rhinoviruses and milk-borne cytomegalovirus in vitro. J Med Microbiol 2000; 49: 719-23.
[63]
Asanuma H, Numazaki K, Nagata N, Hotsubo T, Horino K, Chiba S. Role of milk whey in the transmission of human cytomegalovirus infection by breast milk. Microbiol Immunol 1996; 40: 201-4.
[64]
Ehlinger EP, Webster EM, Kang HH, et al. Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants. J Infect Dis 2011; 204: 1672-82.
[65]
Clarke LM, Durr A, Feldman J, Sierra MF, Daidone BJ, Landesman SH. Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1-seronegative and -seropositive women from an urban minority community. J Infect Dis 1996; 173: 77-82.
[66]
Roxby AC, Atkinson C, Asbjornsdottir K, et al. Maternal valacyclovir and infant cytomegalovirus acquisition: A randomized controlled trial among HIV-infected women. PLoS One 2014; 9: 87855.
[67]
Sagar M. Origin of the transmitted virus in HIV infection: infected cells versus cell free virus. J Infect Dis 2014; 210: S667-73.
[68]
Viljoen J, Tuaillon E, Nagot N, et al. Cytomegalovirus, and possibly Epstein–Barr virus, shedding in breast milk is associated with HIV-1 transmission by breastfeeding. AIDS 2015; 29: 145-53.
[69]
Kovacs A, Schluchter M, Easley K, et al. Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. N Engl J Med 1999; 341: 77-84.
[70]
Slyker J, Farquhar C, Atkinson C, et al. Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection. Clin Infect Dis 2014; 58: 564-72.
[71]
Peckham CS, Johnson C, Ades A, Pearl K, Chin KS. Early acquisition of cytomegalovirus infection. Arch Dis Child 1987; 62: 780-5.
[72]
Minamishima I, Ueda K, Minematsu T, et al. Role of breast milk in acquisition of cytomegalovirus infection. Microbiol Immunol 1994; 38: 549-52.
[73]
Capretti MG, Lanari M, Lazzarotto T, et al. Very low birth weight infants born to cytomegalovirus-seropositive mothers fed with their mother’s milk: A prospective study. J Pediatr 2009; 154: 842-8.
[74]
Richter D, Hampl W, Pohlandt F. Vertical transmission of cytomegalovirus, most probably by breast milk, to an infant with Wiskott-Aldrich syndrome with fatal outcome. Eur J Pediatr 1997; 156: 854-5.
[75]
Stagno S, Brasfield DM, Brown MB, et al. Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study. Pediatrics 1981; 68: 322-9.
[76]
Ballard RA, Drew WL, Hufnagle KG, Riedel PA. Acquired cytomegalovirus infection in preterm infants. Am J Dis Child 1979; 133: 482-5.
[77]
Hamprecht K, Goeiz R, Maschmann J. Breast milk and cytomegalovirus infection in preterm infants. Early Hum Dev 2005; 81: 989-96.
[78]
Pietrasanta C, Ghirardi B, Manca MF, et al. Herpesviruses and breast milk. Pediatr Med Chir 2014; 36: 5.
[79]
Jim WT, Shu CH, Chiu NC, et al. High cytomegalovirus load and prolonged virus excretion in breast milk increase risk for viral acquisition by very low birth weight infants. Pediatr Infect Dis J 2009; 28: 891-4.
[80]
Schleiss MR. Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern? Rev Med Virol 2006; 16: 73-82.
[81]
Numazaki K. Human cytomegalovirus infection of breast milk. FEMS Immunol Med Microbiol 1997; 18: 91-8.
[82]
Doctor S, Friedman S, Dunn MS, et al. Cytomegalovirus transmission to extremely low-birthweight infants through breast milk. Acta Paediatr 2005; 94: 53-8.
[83]
Cheong JL, Cowan FM, Modi N. Gastrointestinal manifestations of postnatal cytomegalovirus infection in infants admitted to a neonatal intensive care unit over a five year period. Arch Dis Child Fetal Neonatal Ed 2004; 89: F367-9.
[84]
Sawyer MH, Edwards DK, Spector SA. Cytomegalovirus infection and bronchopulmonary dysplasia in premature infants. Am J Dis Child 1987; 141: 303-5.
[85]
Kelly MS, Benjamin DK, Puopolo KM, et al. Postnatal cytomegalovirus infection and the risk for bronchopulmonary dysplasia. JAMA Pediatr 2015; 169: 153785.
[86]
Lopes AA, Belhabri S, Karaoui L. Clinical findings and autopsy of a preterm infant with breast milk-acquired cytomegalovirus infection. AJP Rep 2016; 6: 198-202.
[87]
Wakabayashi H, Mizuno K, Kohda C, et al. Low HCMV DNA copies can establish infection and result in significant symptoms in extremely preterm infants: A prospective study. Am J Perinatol 2012; 29: 377-82.
[88]
Mehler K, Oberthuer A, Lang-Roth R, et al. High rate of symptomatic cytomegalovirus infection in extremely low gestational age preterm infants of 22-24 weeks’ gestation after transmission via breast milk. Neonatology 2014; 105: 27-32.
[89]
Hamele M, Flanagan R, Loomis CA, Stevens T, Fairchok MP. Severe morbidity and mortality with breast milk associated cytomegalovirus infection. Pediatr Infect Dis J 2010; 29: 84-6.
[90]
Goelz R, Hihn E, Hamprecht K, et al. Effects of different CMV-heat-inactivation methods on growth factors in human breast milk. Pediatr Res 2009; 65: 458-61.
[91]
Miron D, Brosilow S, Felszer K, et al. Incidence and clinical manifestations of breast milk-acquired cytomegalovirus infection in low birth weight infants. J Perinatol 2005; 25: 299-303.
[92]
Baquero-Artigao F. Grupo de estudio de la infección congénita por citomegalovirus de la Sociedad Española de Infectología PediátricaConsensus document from the Spanish Society of Paediatric Infectious Diseases (SEIP) on the diagnosis and treatment of congenital cytomegalovirus infection An Pediatr (Barc) 2009; 71: 535-47.
[93]
Reina J, Weber I, Riera E, Busquets M, Morales C. Usefulness of a real-time quantitative Polymerase-Chain Reaction (PCR) assay for the diagnosis of congenital and postnatal cytomegalovirus infection. An Pediatr (Barc) 2014; 80: 299-303.
[94]
Klein JO, Wilson CB, Nizet V, Maldonado YA. Infectious Diseases of the Fetus and Newborn Infant. 7th ed. Philadelphia: Elsevier 2011.
[95]
Peila C, Moro GE, Bertino E, et al. The effect of Holder pasteurization on nutrients and biologically-active components in donor human milk: A review. Nutrients 2016; 8: 477.
[96]
Lloyd ML, Hod N, Jayaraman J, et al. Inactivation of cytomegalovirus in breast milk using ultraviolet-C irradiation: opportunities for a new treatment option in breast milk banking. PLoS One 2016; 11: 0161116.
[97]
Dworsky M, Stagno S, Pass RF, Cassady G, Alford C. Persistence of cytomegalovirus in human milk after storage. J Pediatr 1982; 101: 440-3.
[98]
Ford JE, Law BA, Marshall VM, Reiter B. Influence of the heat treatment of human milk on some of its protective constituents. J Pediatr 1977; 90: 29-35.
[99]
Evans TJ, Ryley HC, Neale LM, Dodge JA, Lewarne VM. Effect of storage and heat on antimicrobial proteins in human milk. Arch Dis Child 1978; 53: 239-41.
[100]
Goldblum RM, Dill CW, Albrecht TB, Alford ES, Garza C, Goldman AS. Rapid high-temperature treatment of human milk. J Pediatr 1984; 104: 380-5.
[101]
Curtis N, Chau L, Garland S, Tabrizi S, Alexander R, Morley CJ. Cytomegalovirus remains viable in naturally infected breast milk despite being frozen for 10 days. Arch Dis Child Fetal Neonatal Ed 2005; 90: F529-30.
[102]
Hosseini M, Esmaili HA, Abdoli OS, et al. Evaluation of the freeze-thawing method in reducing viral load of Cytomegalovirus in breast milk of mothers of preterm infants. Breastfeed Med 2016; 11: 557-60.
[103]
Stronati M, Lombardi G, Di Comite A, Fanos V. Breastfeeding and cytomegalovirus infections. J Chemother 2007; 19: 49-51.
[104]
Ben-Shoshan M, Mandel D, Lubetzky R, Dollberg S, Mimouni FB. Eradication of cytomegalovirus from human milk by microwave irradiation: A pilot study. Breastfeed Med 2016; 11: 186-7.
[105]
Tacken KJ, Vogelsang A, van Lingen RA, Slootstra J, Dikkeschei BD, van Zoeren-Grobben D. Loss of triglycerides and carotenoids in human milk after processing. Arch Dis Child Fetal Neonatal Ed 2009; 94: F447-5.
[106]
Friis H, Andersen HK. Rate of inactivation of cytomegalovirus in raw banked milk during storage at -20 degrees C and pasteurisation. Br Med J (Clin Res Ed) 1982; 285: 1604-5.
[107]
Ewaschuk JB, Unger S, O’Connor DL, et al. Effect of pasteurization on selected immune components of donated human breast milk. J Perinatol 2011; 31: 593-8.
[108]
Forsgren M. Cytomegalovirus in breast milk: Reassessment of pasteurization and freeze-thawing. Pediatr Res 2004; 56: 526-8.
[109]
Mussi-Pinhata MM, Yamamoto AY, do Carmo Rego MA, Pinto PC, da Motta MS, Calixto C. Perinatal or early-postnatal cytomegalovirus infection in preterm infants under 34 weeks gestation born to CMV-seropositive mothers within a high-seroprevalence population. J Pediatr 2004; 145: 685-8.
[110]
Kumar M, Nankervis GA, Jacobs IB. Congenitally and postnatally acquired cytomegalovirus infections: long-term follow-up. J Pediatr 1984; 104: 674-9.
[111]
Granstrom M, Leinikki P, Santavuori P, Pettay O. Perinatal cytomegalovirus infection in man. Arch Dis Child 1977; 52: 354-9.
[112]
Paryani SG, Yeager AS, Hosford-Dunn H, et al. Sequelae of acquired Cytomegalovirus infection in premature and sick term infants. J Pediatr 1985; 107: 451-6.
[113]
Bevot A, Hamprecht K, Krageloh-Mann I, Brosch S, Goelz R, Vollmer B. Long-term outcome in preterm children with human cytomegalovirus infection transmitted via breast milk. Acta Paediatr 2012; 101: e167-72.
[114]
Vollmer B, Seibold-Weiger K, Schmitz-Salue C, et al. Postnatally acquired cytomegalovirus infection via breast milk: Effects on hearing and development in preterm infants. Paediatric Infect Dis J 2004; 23: 322-7.
[115]
Luck S, Sharland M. Postnatal cytomegalovirus: Innocent bystander or hidden problem? Arch Dis Child Fetal Neonatal Ed 2009; 94: F58-64.
[116]
Goeltz R, Meisner C, Bevot A, Hamprecht K, Kraegeloh-Mann I, Poets CF. Long-term cognitive and neurological outcome of preterm infants with postnatally acquired CMV infection through breast milk. Arch Dis Child Fetal Neonatal 2013; 98: 430-3.
[117]
Brecht KF, Goelz R, Bevot A, Krageloh-Mann I, Wilke M, Lidzba K. Postnatal human cytomegalovirus infection in preterm infants has long term neuropsychological sequelae. J Pediatr 2015; 166: 834-9.
[118]
Nijman J, Gunkel J, de Vries LS, et al. Reduced occipital fractional anisotropy on cerebral diffusion tensor imaging in preterm infants with postnatally acquired cytomegalovirus infection. Neonatology 2013; 104: 143-50.
[119]
Dorn M, Lidzba K, Bevot A, Goelz R, Hauser TK, Wilke M. Long-term neurobiological consequences of early postnatal hCMV infection in former preterms: A functional MRI study. Hum Brain Mapp 2014; 35: 2594-606.
[120]
Centers for Disease Control and Prevention. Preventing Congenital CMV Infection Available at:. http://www.cdc. gov/cmv/prevention. html2011.
[121]
Barberini L, Noto A, Saba L, et al. Multivariate data validation for investigating primary HCMV infection in pregnancy. Data in Brief 2016; 9: 220-30.
[122]
Fattuoni C, Palmas F, Noto A, et al. Primary HCMV infection in pregnancy from classic data towards metabolomics: An exploratory analysis. Clin Chim Acta 2016; 460: 23-32.
[123]
Fanos V, Atzori L, Makarenko K, Melis GB, Ferrazzi E. Metabolomics application in maternal-fetal medicine. Biomed Res Internat 2013; Article ID 720514.
[124]
Kimberlin DW, Brady MT, Jackson MA. Red Book: Report of the committee on infectious diseases, 31st edition. AAP committee on infectious diseases In: . 2018; pp. 117-20.
[125]
Alarcón Allen A, Baquero-Artigao F. Grupo de estudio de la infección por citomegalovirus de la Sociedad Espanola de Infectología Pediátrica. Revisión y recomendaciones sobre la prevención, diagnóstico y tratamiento de la infección posnatal por citomegalovirus. An Pediatr (Barc) 2011; 74: 52.e1-52.e13.
[126]
Omarsdottir S, Casper C, Navér L, et al. Cytomegalovirus Infection and Neonatal Outcome in Extremely Preterm Infants After Freezing of Maternal Milk. Pediatr Infect Dis J 2015; 34: 482-9.
[127]
Picaud JC, Buffin R, Gremmo‐Feger G, Rigo J, Putet G, Casper C. Working group of the French Neonatal Society on fresh human milk use in preterm infants. Review concludes that specific recommendations are needed to harmonise the provision of fresh mother’s milk to their preterm infants. Acta Paediatrica 2018; 107: 1145-55.
Related Books
Common Pediatric Diseases: an Updated Review
Article Metrics
113
18
1
2